Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
| Current Price | ₹4,514.50 |
|---|---|
| Market Cap | ₹20,653 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 28.6 |
| Return on Equity | 17.16% |
| 52-Week Range | ₹4,396.70 – ₹5,993.00 |
| Beta (1Y) | 0.45 |
| Dividend Yield | 1.66% |
1. Pharmaceuticals-100%
Pfizer Ltd. is trading at ₹4,514.50, with a market capitalisation of ₹20,653 Cr.
Pfizer Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Pfizer Ltd. has a P/E of 28.6 and a return on equity of 17.16%.